Loading insider details...
Latest Form 4 (Jun 18, 2026): Grant/Award of 3,772 MIRM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/Award | 3,772 | n/a |
| Jun 5, 2026 | MBX Biosciences, Inc. (MBX) | Grant/Award | 12,500 | n/a |
| Jan 27, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Other (see footnotes) | 159,277 | n/a |
| Sep 30, 2025 | MBX Biosciences, Inc. (MBX) | Purchase | 666,666 | $12.00M |
| Jun 17, 2025 | Arcutis Biotherapeutics, Inc. (ARQT) | Purchase | 2,646 | $34.6K |
| Jun 17, 2025 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/Award | 7,609 | n/a |
| Jun 6, 2025 | Arcutis Biotherapeutics, Inc. (ARQT) | Purchase | 1,890 | $25.2K |
| Jun 6, 2025 | MBX Biosciences, Inc. (MBX) | Grant/Award | 16,000 | n/a |
| Jun 2, 2025 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 5,703 | n/a |
| May 23, 2025 | Arcutis Biotherapeutics, Inc. (ARQT) | Purchase | 2,520 | $34.4K |